Research description
My research focus is translational bioinformatics applied to cancer metabolism towards the discovery, development, and validation of novel diagnostic and therapeutic approaches in cancer. Affiliated to Prof. Jonas Bergh lab in OnkPat.
- Co-authored 32 publications (13 as first author, 6 as senior or corresponding)
- Google Scholar profile
- ORCID profile
- Web of Science profile
Key Publications
- Gatto F, et al. (2023), Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study. JCO Precision Oncology e2200361
- Bratulic S, …, Gatto F (2022) Noninvasive detection of any-stage cancer using free glycosaminoglycans. Proceedings of the National Acadamy of Science USA, 119 (50) e2115328119
- Gatto F, et al. (2022), Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Non-Metastatic Renal Cell Carcinoma – a Prospective Cohort Study. European Urology Open Science 42, 30-39
- Bratulic S, …, Gatto F (2022) Analysis of Normal Levels of Free Glycosaminoglycans in Urine and Plasma in Adults. Journal of Biological Chemistry, 101575
- Gatto F, Ferreira R, Nielsen J (2019) Pan-cancer analysis of the metabolic reaction network. Metabolic Engineering, 57, 51-62
- Gatto F, et al. (2018) Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma, European Urology Oncology 1 (5), 364-377
- Brunk E, …, Gatto F, et al. (2018) Recon3D: A Resource Enabling A Three-Dimensional View of Gene Variation in Human Metabolism, Nature Biotechnology 36 (3), 272
- Gatto F, Schulze A, Nielsen J (2016) Systematic analysis reveals that cancer mutations converge on deregulated metabolism of arachidonate and xenobiotics. Cell Reports, 16 (3), 878-95
- Gatto F, et al. (2016) Glycosaminoglycan profiling in patients’ plasma and urine predicts occurrence of metastatic clear cell renal cell carcinoma. Cell Reports, 15 (8), 1822-1836
- Gatto F, Nookaew I, Nielsen J (2014) Chromosome 3p loss of heterozygosity uniquely shapes clear cell renal carcinoma metabolism. Proceedings of the National Acadamy of Science USA, 111 (9), E866-E875
Education
- 2015 - Ph.D. in Systems Biology, Chalmers University of Technology, Göteborg, Sweden
- 2011 - M.Sc. in Chemical Engineering, Università degli Studi di Padova, Padova, Italy
- 2009 - B.Sc. in Chemical Engineering, Università degli Studi di Padova, Padova, Italy
Academic honours, awards and prizes
- 2019 - National SKAPA Innovation Prize in memory of Alfred Nobel, SKAPA Foundation, Stockholm, Sweden
- 2019 - Regional SKAPA Innovation Prize in memory of Alfred Nobel, SKAPA Foundation, Stockholm, Sweden
- 2019 - Genetic Engineering and Biotechnology News A-List - Top 10 Under 40 (Global), United States
- 2019 - Karin Markides Innovation Prize Recipient of the Year, Chalmers University of Technology, Göteborg, Sweden
- 2019 - Labiotech.eu Top 10 Young European Biotech Entrepreneurs, Germany
- 2018 - MIT Technology Review Pioneer of the Year (Europe), United States
- 2018 - MIT Technology Review Innovators 35 Under 35 (Europe), United States
- 2017 - 1st Poster Award in Renal Cell Carcinoma, 9th European Multidisciplinary Meeting on Urological Cancers (EMUC17), Barcelona, Spain
- 2015 - Travel Award for Excellent Research Contribution, 11th International Conference on Pathways, Networks, and Systems Medicine, Crete, Greece